<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="letter">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Emerg Infect Dis</journal-id>
      <journal-id journal-id-type="publisher-id">EID</journal-id>
      <journal-title-group>
        <journal-title>Emerging Infectious Diseases</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">1080-6040</issn>
      <issn pub-type="epub">1080-6059</issn>
      <publisher>
        <publisher-name>Centers for Disease Control and Prevention</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">19523317</article-id>
      <article-id pub-id-type="pmc">2727340</article-id>
      <article-id pub-id-type="publisher-id">08-1735</article-id>
      <article-id pub-id-type="doi">10.3201/eid1506.081735</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Letters to the Editor</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title><italic>Escherichia coli</italic> and <italic>Klebsiella pneumoniae</italic> Carbapenemase in Long-term Care Facility, Illinois, USA</article-title>
        <alt-title alt-title-type="running-head"><italic>Escherichia coli</italic> and <italic>Klebsiella pneumoniae</italic> Carbapenemase in Long-term Care Facility, Illinois, USA</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>McGuinn</surname>
            <given-names>Marcella</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Hershow</surname>
            <given-names>Ronald C.</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Janda</surname>
            <given-names>William M.</given-names>
          </name>
        </contrib>
        <aff id="aff1">University of Illinois, Chicago, Illinois, USA</aff>
      </contrib-group>
      <author-notes>
        <corresp id="cor1">Address for correspondence: Marcella McGuinn, Section of Infectious Diseases (MC 735), Rm 887, College of Medicine East, 808 S Wood St, Chicago, IL 60612, USA; email: <email xlink:href="mcguinn@uic.edu">mcguinn@uic.edu</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <month>6</month>
        <year>2009</year>
      </pub-date>
      <volume>15</volume>
      <issue>6</issue>
      <fpage>988</fpage>
      <lpage>989</lpage>
      <kwd-group kwd-group-type="author">
        <title>Keywords: </title>
        <kwd>Escherichia coli</kwd>
        <kwd>Klebsiella pneumoniae carbapenemase</kwd>
        <kwd>bacteria</kwd>
        <kwd>long-term care facility</kwd>
        <kwd>Illinois</kwd>
        <kwd>USA</kwd>
        <kwd>letter</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <p><bold>To the Editor:</bold> <italic>Escherichia coli</italic> harboring <italic>Klebsiella pneumoniae</italic> carbapenemases (KPCs) are now rarely being reported. Worldwide, KPC-2 has been detected in Israel and the People&#x2019;s Republic of China (<xref ref-type="bibr" rid="R1"><italic>1</italic></xref>,<xref ref-type="bibr" rid="R2"><italic>2</italic></xref>). Within the United States, carbapenem-resistant <italic>E. coli</italic> carrying <italic>bla</italic><sub>KPC</sub> has been isolated in New Jersey (<xref ref-type="bibr" rid="R3"><italic>3</italic></xref>) and Cleveland, Ohio (<xref ref-type="bibr" rid="R4"><italic>4</italic></xref>), and 7 carbapenem-resistant <italic>E. coli</italic> isolates were obtained from 3 different hospitals in Brooklyn, New York (<xref ref-type="bibr" rid="R5"><italic>5</italic></xref>). Urban et al. (<xref ref-type="bibr" rid="R6"><italic>6</italic></xref>) recently reported 9 KPC-2 and KPC-3 carbapenemases in urinary <italic>E. coli</italic> isolates from 7 long-term care facilities. We report such an isolate from a resident of a long-term care facility.</p>
    <p>This case involved a 68-year-old female resident of a long-term care facility in Centralia, Illinois, who had multiple chronic medical problems, including cerebral palsy, a seizure disorder, and recurrent urinary tract infections. A urine culture grew &gt;10<sup>5</sup> CFU/mL of <italic>E. coli</italic> susceptible to amikacin, gentamicin, tobramycin, piperacillin/tazobactam, trimethoprim/sulfamethoxazole, imipenem, and nitrofurantoin. Tigecycline susceptibility was not determined. Trimethoprim/sulfamethoxazole therapy was initiated. Follow-up urine culture almost 3 weeks later again grew &gt;10<sup>5</sup> CFU/mL of <italic>E. coli</italic>, now susceptible to amikacin, gentamicin, tobramycin, nitrofurantoin, and tigecycline. The isolate was resistant to imipenem and meropenem. A modified Hodge test demonstrated production of a carbapenemase (<xref ref-type="bibr" rid="R7"><italic>7</italic></xref>), and the <italic>bla</italic><sub>KPC</sub> gene was detected by PCR at the Centers for Disease Control and Prevention (CDC). The patient was treated with a 10-day course of nitrofurantoin, 100 mg by gastrostomy tube 2&#xD7; per day. Chart review indicated that contact precautions were instituted only after discovery of the second <italic>E. coli</italic> isolate.</p>
    <p>Seventeen days later, a repeat urine culture grew &gt;10<sup>5</sup> CFU/mL of <italic>K. pneumoniae</italic> susceptible only to amikacin, gentamicin, tobramycin, and tigecycline. No treatment was given. Follow-up urine culture grew &gt;10<sup>5</sup> CFU/mL of <italic>K. pneumoniae</italic> again with a similar resistance pattern. The modified Hodge test result was positive (<xref ref-type="bibr" rid="R7"><italic>7</italic></xref>) and was confirmed as <italic>bla</italic><sub>KPC</sub> positive by PCR at CDC. The resident was transferred to an acute care facility for further evaluation and was treated with amikacin. At completion of therapy, a repeat urine culture was negative for organisms.</p>
    <p>Our case, like that of Urban et al. (<xref ref-type="bibr" rid="R6"><italic>6</italic></xref>), involved a urinary isolate from a resident of a long-term care facility. As increasing numbers of resistant gram-negative rods colonize such patients, the patients may acquire a bacterium carrying a KPC plasmid conferring broad-spectrum resistance as described in our patient. These plasmids may then be laterally transferred to other gram-negatives, which may have occurred in this case.</p>
    <p>Our case underscores the gravity of the evolutionary process of emergent, multidrug&#x2013;resistant enterobacteriaceae. Even though <italic>E. coli</italic> strains that harbor carbapenemase genes are not ubiquitous, additional therapeutic interventions are needed to prevent the spread of these bacteria, which are likely to infect increasing numbers of patients.</p>
  </body>
  <back>
    <fn-group>
      <fn fn-type="citation">
        <p><italic>Suggested citation for this article</italic>: McGuinn M, Hershow RC, Janda WM. <italic>Escherichia</italic> <italic>coli</italic> and <italic>Klebsiella pneumoniae</italic> carbapenemase in long-term care facility, Illinois, USA [letter]. Emerg Infect Dis [serial on the Internet]. 2009 Jun [<italic>date cited</italic>]. Available from <ext-link ext-link-type="uri" xlink:href="http://www.cdc.gov/eid/content/15/6/988.htm">http://www.cdc.gov/eid/content/15/6/988.htm</ext-link></p>
      </fn>
    </fn-group>
    <ref-list>
      <title>References</title>
      <ref id="R1">
        <label>1. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Navon-Venezia</surname> <given-names>S</given-names></string-name>, <string-name><surname>Chmelnitsky</surname> <given-names>I</given-names></string-name>, <string-name><surname>Leavitt</surname> <given-names>A</given-names></string-name>, <string-name><surname>Schwaber</surname> <given-names>M</given-names></string-name>, <string-name><surname>Schwartz</surname> <given-names>D</given-names></string-name>, <string-name><surname>Carmeli</surname> <given-names>Y</given-names></string-name> <article-title>Plasmid-mediated imipenem-hydrolyzing enzyme KPC-2 among multiple carbapenem-resistant <italic>Escherichia coli</italic> clones in Israel.</article-title><source>Antimicrob Agents Chemother</source> <year>2006</year>;<volume>50</volume>:<fpage>3098</fpage>&#x2013;<lpage>101</lpage> <pub-id pub-id-type="doi">10.1128/AAC.00438-06</pub-id><pub-id pub-id-type="pmid">16940107</pub-id></mixed-citation>
      </ref>
      <ref id="R2">
        <label>2. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Cai</surname> <given-names>JC</given-names></string-name>, <string-name><surname>Zhou</surname> <given-names>HW</given-names></string-name>, <string-name><surname>Zhang</surname> <given-names>R</given-names></string-name>, <string-name><surname>Chen</surname> <given-names>GX</given-names></string-name> <article-title>Emergence of <italic>Serratia marcescens, Klebsiella pneumoniae</italic>, and <italic>Escherichia coli</italic> isolates possessing the plasmid-mediated carbapenem-hydrolyzing &#x3B2;-lactamase KPC-2 in intensive care units of Chinese hospital.</article-title><source>Antimicrob Agents Chemother</source> <year>2008</year>;<volume>52</volume>:<fpage>2014</fpage>&#x2013;<lpage>8</lpage> <pub-id pub-id-type="doi">10.1128/AAC.01539-07</pub-id><pub-id pub-id-type="pmid">18332176</pub-id></mixed-citation>
      </ref>
      <ref id="R3">
        <label>3. </label>
        <mixed-citation publication-type="confproc"><string-name><surname>Hong</surname> <given-names>T</given-names></string-name>, <string-name><surname>Moland</surname> <given-names>ES</given-names></string-name>, <string-name><surname>Abdalhamid</surname> <given-names>B</given-names></string-name>, <string-name><surname>Hanson</surname> <given-names>ND</given-names></string-name>, <string-name><surname>Wang</surname> <given-names>J</given-names></string-name>, <string-name><surname>Sloan</surname> <given-names>C</given-names></string-name>, <etal/><italic>E. coli</italic> producing KPC-3 carapenem hydrolyzing enzyme. In: Program and abstracts of the 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy (Chicago). Washington: American Society for Microbiology; <year>2003</year> p. 75. Abstract C1-265.</mixed-citation>
      </ref>
      <ref id="R4">
        <label>4. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Deshpande</surname> <given-names>LM</given-names></string-name>, <string-name><surname>Rhomberg</surname> <given-names>PR</given-names></string-name>, <string-name><surname>Sader</surname> <given-names>HS</given-names></string-name>, <string-name><surname>Jones</surname> <given-names>RN</given-names></string-name> <article-title>Emergence of serine carbapenemases (KPC and SME) among clinical strains of <italic>Enterobacteriaceae</italic> isolated in the United States Medical Centers: Report from the MYSTIC Program (1999&#x2013;2005).</article-title><source>Diagn Microbiol Infect Dis</source> <year>2006</year>;<volume>56</volume>:<fpage>367</fpage>&#x2013;<lpage>72</lpage> <pub-id pub-id-type="doi">10.1016/j.diagmicrobio.2006.07.004</pub-id><pub-id pub-id-type="pmid">17020798</pub-id></mixed-citation>
      </ref>
      <ref id="R5">
        <label>5. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Bratu</surname> <given-names>S</given-names></string-name>, <string-name><surname>Brooks</surname> <given-names>S</given-names></string-name>, <string-name><surname>Burney</surname> <given-names>S</given-names></string-name>, <string-name><surname>Kochar</surname> <given-names>S</given-names></string-name>, <string-name><surname>Gupta</surname> <given-names>J</given-names></string-name>, <string-name><surname>Landman</surname> <given-names>D</given-names></string-name>, <etal/><article-title>Detection and spread of <italic>Escherichia coli</italic> possessing the plasmid-borne carbapenemase KPC-2 in Brooklyn, New York.</article-title><source>Clin Infect Dis</source> <year>2007</year>;<volume>44</volume>:<fpage>972</fpage>&#x2013;<lpage>5</lpage> <pub-id pub-id-type="doi">10.1086/512370</pub-id><pub-id pub-id-type="pmid">17342651</pub-id></mixed-citation>
      </ref>
      <ref id="R6">
        <label>6. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Urban</surname> <given-names>C</given-names></string-name>, <string-name><surname>Bradford</surname> <given-names>PA</given-names></string-name>, <string-name><surname>Tuckman</surname> <given-names>M</given-names></string-name>, Segal-Maurer S, Wehbeh W, Grenner L, et al. <article-title>Carbapenem-resistant <italic>Escherichia coli</italic> harboring <italic>Klebsiella pneumoniae</italic> carbapenemase &#x3B2;-lactamases associated with long-term care facilities.</article-title><source>Clin Infect Dis</source> <year>2008</year>;<volume>46</volume>:<fpage>e127</fpage>&#x2013;<lpage>30</lpage> <pub-id pub-id-type="doi">10.1086/588048</pub-id><pub-id pub-id-type="pmid">18419424</pub-id></mixed-citation>
      </ref>
      <ref id="R7">
        <label>7. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Anderson</surname> <given-names>KF</given-names></string-name>, <string-name><surname>Lonsway</surname> <given-names>DR</given-names></string-name>, <string-name><surname>Rasheed</surname> <given-names>JK</given-names></string-name>, <string-name><surname>Biddle</surname> <given-names>J</given-names></string-name>, <string-name><surname>Jensen</surname> <given-names>B</given-names></string-name>, <string-name><surname>McDougal</surname> <given-names>LK</given-names></string-name>, <etal/><article-title>Evaluation of methods to identify the <italic>Klebsiella pneumoniae</italic> carbapenemase in <italic>Enterobacteriaceae.</italic></article-title><source>J Clin Microbiol</source> <year>2007</year>;<volume>45</volume>:<fpage>2723</fpage>&#x2013;<lpage>5</lpage> <pub-id pub-id-type="doi">10.1128/JCM.00015-07</pub-id><pub-id pub-id-type="pmid">17581941</pub-id></mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
